Solid Tumors Harboring NTRK Fusion Completed Phase Trials for Larotrectinib (DB14723)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

IndicationStatusPhase
DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05192642A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice